@saakohl
Today we're launching Latent-Y: the world's first autonomous agent for drug design, lab-validated end to end. Give it a research goal. Latent-Y reasons, designs, iterates, and delivers lab-ready antibodies, autonomously or collaboratively, with the biological reasoning of a PhD protein design expert. Technical report: https://t.co/E7IHfkvvD3 Blog post: https://t.co/GfJAfzj0Qx Apply for access: https://t.co/E0SR9znZiP